COMPANY

OmniCyte

Our biologic therapeutic is a bi-specific multimeric viral glycoprotein and tumor associated antigen complex (VGP/TAA). From company website Source · Oct 13, 2026

Keywords: oncology cancer

Profile checked Oct 10, 2026

2NIH grants

NIH awards 2

Annual award amounts. Total $373K.

Jul 8, 2014 NIH award 3R41CA162587-01A1S1 FY2014: $173,412 awarded for that fiscal year; activity R41 (STTR); PI LEONARDI, PETER; recipient as written: OMNICYTE, NEW YORK, NY. Diagnosis, Prognosis and Treatment of hRgr associate source ↗
Sep 26, 2012 NIH award 1R41CA162587-01A1 FY2012: $199,179 awarded for that fiscal year; activity R41 (STTR); PI LEONARDI, PETER; recipient as written: OMNICYTE, NEW YORK, NY. Diagnosis, Prognosis and Treatment of hRgr associated source ↗